• Accelerating TB vaccine Research & Development through partnership
    • TBVI TBVI TBVI
    • Home
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Operational Office
        • Product and Clinical Development Team
        • Portfolio Management Committee
      • TBVI consortium
      • Key achievements and impact
      • Financials
      • Connect
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • For partners
      • For researchers and vaccine developers
        • Partners pages
        • Become a TBVI partner
        • Access to services
        • Conferences, meetings and workshops
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project description
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 developments
      • MTBVAC in Newborns
        • MTBVAC in newborns
        • Coordinator and partners
        • News and Publications
        • Communication tools
      • For funders
        • TBVI R&D priorities and funding opportunities
        • 2015-2017 TBVI service provision and funding opportunities
        • Why invest in TBVI
    • News & events
      • News
      • Events

    Archives

    Monthly Archive for: "January, 2018"
    Home / 2018 / January
      0
    By Cora Agterdenbosch
    In News Posted January 18, 2018

    JPI AMR call

    The Joint Programming Initiative on Antimicrobial Resistance (JPI AMR) published a call that offers opportunities for our partners: “Innovations against antibiotic-resistant bacteria: new [...]

    Read More
      0
    By Cora Agterdenbosch
    In News Posted January 17, 2018

    BMJ article

    Oxford response to recent BMJ article. Read the article.  

    Read More
    Load More
    Menu
    • Home
    • About us
    • What we do
    • How we work
    • For researchers and vaccine developers
    • For funders
    • Pipeline of vaccines
    • News
    TuBerculosis Vaccine Initiative (TBVI)

    Runderweg 6
    8219 PK Lelystad
    The Netherlands
    Email: info@tbvi.eu
    Phone: +31 320 277 550

    © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

    Start typing and press Enter to search